Open Beta
TREN
MetriLume
TREN

US marketsBIOA

SEC-sourced researchBeta

BIOA

BioAge Labs, Inc.

Company comparison ↗

Data passport

CIK
0001709941
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 0.0000 USD; December 2025: 8,995,000.0000 USD9M USD0 USD0December 2024December 2025
BIOA · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20240.0000Mar 24, 2026
December 20258,995,000.0000Mar 24, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20258,995,000.0000-80,605,000.0000-81,627,000.0000294,889,000.000022,838,000.0000Mar 24, 2026
December 20240.0000-71,109,000.0000-51,522,000.0000358,234,000.000035,107,000.0000Mar 24, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$9MDecember 2025Mar 24, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$0December 2024Mar 24, 202610-K
Net incomeNetIncomeLoss-$80.61MDecember 2025Mar 24, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$81.63MDecember 2025Mar 24, 202610-K
Total assetsAssets$294.89MDecember 2025Mar 24, 202610-K
Total liabilitiesLiabilities$22.84MDecember 2025Mar 24, 202610-K

New filings

Explore methodology ↗